ISI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ionis Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 67.36 EUR Market Closed

Market Cap: €5.9B

I	Ionis Pharmaceuticals Inc XBER:ISI	US
E	Esperion Therapeutics Inc F:0ET	US
F	Flex Ltd F:FXI	SG

Profitability Summary

Ionis Pharmaceuticals Inc's profitability score is 42/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

99%

Gross Margin is Increasing

98% > 98%

Negative Operating Margin

-40%

Negative 3Y Average Operating Margin

-55%

Operating Margin is Increasing

-81% > -40%

Negative Net Margin

-40%

Negative 3Y Average Net Margin

-48%

Net Margin is Increasing

-57% > -40%

Negative Free Cash Flow Margin

-34%

Negative 3Y Average Free Cash Flow Margin

-56%

Free Cash Flow Margin is Increasing

-69% > -34%

Negative ROE

-71%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

33%

ROIC is Increasing

-102% > 133%

View All

Hide

Collapse

42 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

99%

Gross Margin is Increasing

98% > 98%

Negative Operating Margin

-40%

Negative 3Y Average Operating Margin

-55%

Operating Margin is Increasing

-81% > -40%